Free clinical-trial enrollment research note — July 2026

A free market note on where clinical-trial enrollment stands, July 2026 — new registrations, enrollment-distress signals, and the overdue-results backlog. Compiled from Eichor's daily scan of public ClinicalTrials.gov records. Aggregate only; no individual trial is named.

What's inside:

Weekly new-registration counts through mid-July, with the therapeutic-area mix.
Where enrollment-distress signals concentrate — and why rare disease and oncology dominate.
The Eichor Overdue-Results Index, what it measures, and what it does not.
A short read on what the July pattern means for site selection in the crowded indications.

Free, no card. Leave a work email and we'll send you the link — usually within the hour. The underlying live figures are always free and public at eichor.com/facts.

By requesting the note you'll receive this one email; we don't share your address. See our privacy policy.

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.